{"id":"sevoflurane-inhalant-product","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Postoperative nausea and vomiting"},{"rate":"5-15","effect":"Emergence delirium"},{"rate":"5-10","effect":"Airway irritation"},{"rate":"10-20","effect":"Hypotension"},{"rate":"5-15","effect":"Bradycardia"},{"rate":"<1","effect":"Hepatotoxicity (rare)"}]},"_chembl":{"chemblId":"CHEMBL1200694","moleculeType":"Small molecule","molecularWeight":"200.05"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sevoflurane is a halogenated ether that acts as a general anesthetic by modulating multiple ion channels and neurotransmitter receptors in the brain. It enhances the activity of inhibitory GABA-A receptors while simultaneously blocking excitatory NMDA glutamate receptors, resulting in rapid loss of consciousness and anesthesia. The exact molecular mechanism remains incompletely understood but involves disruption of neuronal signaling at multiple levels.","oneSentence":"Sevoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory GABA neurotransmission and inhibiting excitatory glutamate signaling.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:40.431Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction and maintenance of general anesthesia in adults and pediatric patients"},{"name":"Sedation in mechanically ventilated patients in intensive care settings"}]},"trialDetails":[{"nctId":"NCT04415060","phase":"PHASE3","title":"SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-06-15","conditions":"Covid19, Hypoxic Respiratory Failure","enrollment":800},{"nctId":"NCT06835010","phase":"NA","title":"Sevoflurane and Dexmedetomidine's Contrasting Renal Impacts After Non-Cardiac Surgery","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-05-20","conditions":"AKI - Acute Kidney Injury","enrollment":90},{"nctId":"NCT05289349","phase":"NA","title":"Propofol or Sevoflurane Anesthesia in Egyptian Patients","status":"COMPLETED","sponsor":"Rehab Werida","startDate":"2021-12-01","conditions":"Anesthesia","enrollment":44},{"nctId":"NCT06241131","phase":"EARLY_PHASE1","title":"The Quality of Recovery From General Anesthesia With Desflurane for Fundus Surgery","status":"UNKNOWN","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-03-01","conditions":"Desflurane Anesthesia, Postoperative Recovery","enrollment":220},{"nctId":"NCT04239794","phase":"NA","title":"The Influence of Type of Anesthesia on Postoperative Pain","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2020-02-20","conditions":"Colo-rectal Cancer, Anesthesia","enrollment":468},{"nctId":"NCT05993039","phase":"EARLY_PHASE1","title":"Inhalational Anesthesia vs TIVA in Endoscopic Tympanoplasty","status":"UNKNOWN","sponsor":"Our Lady of the Lake Hospital","startDate":"2023-09-01","conditions":"Perforated Eardrum","enrollment":100},{"nctId":"NCT05102422","phase":"","title":"Quantitative Electroencephalogram and Bispectral Index Brain Mapping During Propofol vs Sevoflurane General Anesthesia","status":"COMPLETED","sponsor":"Pierre Pandin","startDate":"2007-08-21","conditions":"Neurophysiology","enrollment":40},{"nctId":"NCT04802122","phase":"PHASE4","title":"Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects.","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2021-05-24","conditions":"Anesthesia Intubation Complication, Cardiovascular Complication, Intubation","enrollment":60},{"nctId":"NCT04813952","phase":"NA","title":"The Effect of Minimal Flow Sevoflurane Anesthesia","status":"COMPLETED","sponsor":"Sisli Hamidiye Etfal Training and Research Hospital","startDate":"2021-02-15","conditions":"Anesthesia; Functional, Anesthesia Awareness","enrollment":70},{"nctId":"NCT04950205","phase":"EARLY_PHASE1","title":"Influence of Postoperative Cognitive Function in Patients With Sevoflurane Postconditioning on Carotid Intima Stripped","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-06-01","conditions":"Postoperative Cognitive Dysfunction, Sevoflurane, Carotid Artery Intima Stripped","enrollment":140},{"nctId":"NCT04839536","phase":"PHASE4","title":"Comparing Sevoflurane With Propofol Sedation in ESRF Patients","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2021-04-01","conditions":"Sevoflurane, Kidney Diseases, Procedural Hypotension","enrollment":36},{"nctId":"NCT04289090","phase":"PHASE4","title":"Sevoflurane Versus Propofol on Optic Nerve Sheath Diameter During Anesthesia in Steep Trendelenburg Position","status":"UNKNOWN","sponsor":"State University of New York - Downstate Medical Center","startDate":"2020-01-14","conditions":"Percentage of Change in ONSD During Anesthesia With Sevoflurane Versus Propofol in Two Groups of Patients","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":113,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ultane, 74412392","Sevorane","Sevoflurane"],"phase":"marketed","status":"active","brandName":"Sevoflurane inhalant product","genericName":"Sevoflurane inhalant product","companyName":"Sunnybrook Health Sciences Centre","companyId":"sunnybrook-health-sciences-centre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sevoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory GABA neurotransmission and inhibiting excitatory glutamate signaling. Used for Induction and maintenance of general anesthesia in adults and pediatric patients, Sedation in mechanically ventilated patients in intensive care settings.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":6,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}